Physician profile
Jonathan Golani
NPI 1629573845
$2,498.80
in general payments reported to CMS, 2019-2025
17 companies · $1,073 in 2025
The $1,073 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $306 · 2023: $688 · 2024: $432 · 2025: $1,073.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,192.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $387.14 | 2023-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Edwards Lifesciences Corporation | $357.00 | 2022-2023 | Sapien 3 Ultra Resilia |
| Medtronic, INC. | $335.83 | 2023-2025 | Interstim, Symplicity G3 |
| Teleflex LLC | $282.56 | 2023-2024 | Urolift |
| Astrazeneca Pharmaceuticals LP | $268.82 | 2022-2025 | Farxiga, Breztri |
| Novo Nordisk INC | $143.34 | 2025 | Wegovy, Ozempic, Rybelsus |
| Teva Pharmaceuticals USA, INC. | $116.49 | 2023 | Austedo |
| Biotronik INC. | $113.79 | 2025 | Biomonitor |
| Exact Sciences Corporation | $113.55 | 2025 | Cologuard Collection Kit |
| Abiomed | $112.61 | 2025 | |
| Lilly USA, LLC | $73.34 | 2024-2025 | Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $64.59 | 2025 | |
| Corcept Therapeutics | $57.27 | 2025 | Korlym |
| Sanofi-Aventis U.S. LLC | $19.62 | 2025 | |
| Amgen INC. | $18.53 | 2024 | Prolia, Evenity |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynavax Technologies Corporation | $18.03 | 2025 | Heplisav-B |
| Gilead Sciences, INC. | $16.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Golani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.